Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
ENSG · NASDAQ · Health Care Facilities
Ensign Group (ENSG) · oqro.io/stocks/ENSG · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$176.59−6.39 (−3.49%)
Close of Nov 19, 2026, vs Nov 18 · end-of-day
No open-market purchase by an insider of Ensign Group was filed in the last 90 days. The latest on record was on Apr 30, 2024.
Since 2007, Ensign Group insiders reported 17 open-market purchases and 878 sales on Forms 4 and 5, with purchases in 6 different years, most recently 2024.
In the last 90 days, 1 insider of Ensign Group (ENSG) reported 1 open-market sale worth $18K in total on SEC Form 4. The largest seller by value was Mark Vincent Parkinson, with $18K. Many insider sales follow a plan set in advance or cover taxes on stock awards; the filing says what was sold, not the reason.
No trade in Ensign Group (ENSG) was disclosed by a member of Congress in the last 12 months.
Ensign Group's next results are expected on Feb 2, 2027, after the market closes. The date can move until the company confirms it. Insiders often trade in the weeks right after results.
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
−1.2% (−$2.12) from Nov 19, 2025 to Nov 19, 2026 · adjusted daily closes
Adjusted close went from $178.71 on Nov 19, 2025 to $176.59 on Nov 19, 2026 (−1.2%). Disclosed in this range: 0 insider trades, 38 pre-arranged insider sales, 0 Congress trades, and 30 13F position changes for 4 quarters ending in it.
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Health Care Facilities company based in San Juan Capistrano, California.
Last 12 months
−1.2%
Market value
$10.3B
S&P 500 +8.0% over the same dates. Prices adjusted for splits and dividends.
Short interest: 1.47M shares sold short (2.5% of shares outstanding), +5.5% vs the previous count, 3.5 days of normal trading to buy them back. FINRA, as of Oct 30, 2026. Short interest history
Revenue, fiscal 2025
$5.06B
+18.7% vs the year before
Net income, fiscal 2025
$344M
As reported in the annual filing
Shares outstanding
58.3M
As of Oct 22, 2026
In fiscal 2025 the company spent $20M buying back its own shares and $14.4M on dividends. Cash actually paid, from its cash-flow statement.
Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Mark Vincent Parkinson (Director) sold ~$18K of Ensign Group
Fund moves
17 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Insiders of Ensign Group reported 17 open-market purchases and 878 sales since 2007; purchases in 6 different years, most recently 2024.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $4.06M32×32 trades |
| 2025 | — | $20M39×39 trades |
| 2024 | $181×1 trade | $23.4M38×38 trades |
| 2023 | — | $23.1M34×34 trades |
| 2022 | — | $16.5M22×22 trades |
| 2021 | — | $4.87M34×34 trades |
| 2020 | $990K6×6 trades | $15M43×43 trades |
| 2019 | — | $1.78M23×23 trades |
| 2018 | — | $13.5M57×57 trades |
| 2017 | $85K3×3 trades | $1.64M30×30 trades |
| 2016 | — | $1.09M36×36 trades |
| 2015 | — | $6.23B67×67 trades |
| 2014 | — | $374M53×53 trades |
| 2013 | — | $14.5M43×43 trades |
| 2012 | — | $28.9M85×85 trades |
| 2011 | — | $23.5M45×45 trades |
| 2010 | $17K2×2 trades | $28.3M129×129 trades |
| 2009 | $55K3×3 trades | $3.33M36×36 trades |
| 2008 | $82K2×2 trades | $2.14M28×28 trades |
| 2007 | — | $8.48M4×4 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Against the S&P 500 over the year
Since Nov 18, 2025, ENSG is down 1.1% and the index fund is up 8.5%: 10 points behind the market. Traders call a stock that beats the index over a period a relative-strength leader.
How much ENSG moves
Beta 0.1 (1 year vs SPY)
End-of-day prices. These figures describe the past year and say nothing about what comes next. Beta: how much the stock moved, on average, for each 1% move of the S&P 500 fund over 250 trading days (1 = in step with it).
No Schedule 13D or 13G filing on ENSG over the last three years: no investor has reported crossing 5% of its stock in that time.
Source: SEC Schedules 13D and 13G, which anyone owning more than 5% of a class of stock must file. A 13D filer may seek to influence the company; a 13G filer is passive. Filings before December 2024 are free text and read from their cover page: a percent or share count that is not stated plainly is left blank. Each line links to the filing.
Written by OQRO's software from the last 12 months on record · Nov 19, 2026
Every number, name, date and link in the text above comes from this list; software checks that before the text is stored. This text was assembled directly from the facts, without a language model.
Insiders
Funds and stakes
Contracts, lobbying and filings
Company reports, price and press
Who holds it
Things to keep in mind
Revenue
$1.48B
+14.5% vs the same quarter a year earlier
Free cash flow, last 12 months
—
Cash from operations minus capital spending
Net cash
$139M
Debt $199M, cash $338M, at Sep 30, 2026
Net income, last 12 months
$399M
Operating profit covers interest 62.8x
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Oct 27, 2026.
Revenue and earnings history, 17 fiscal yearsEarnings dates and the stock's moves
The three months Jul 1, 2026 to Sep 30, 2026, compared with the same quarter a year earlier, from the quarterly report filed Oct 27, 2026. Quarterly reports are not audited. Read the filing
+15% on the same quarter a year earlier ($1.24B)
+46% on the same quarter a year earlier ($32.6M)
The segments reach the total once $14.3M of items outside them is counted: corporate items, and the removal of sales between segments so they are not counted twice, as the company reports them.
Fiscal year Jan 1, 2025 to Dec 31, 2025, from the annual report filed Feb 4, 2026. Read the filing
+19% on the year before ($4.08B)
+33% on the year before ($95.1M)
The segments reach the total once $93.1M of items outside them is counted: corporate items, and the removal of sales between segments so they are not counted twice, as the company reports them.
Every annual report has a section where the company's managers explain the year's results (Item 7, Management's discussion and analysis). In this report it runs to about 11,000 words.
We are a provider of health care services across the post-acute care continuum. We engage in the operation, ownership, acquisition, development and leasing of skilled nursing, senior living and other healthcare related properties and ancillary businesses located in 17 states. Our independent subsidiaries, each of which strive to be the operation of choice in the communities they serve, provide a broad spectrum of services. As of December 31, 2025, we offered skilled nursing, long term acute care, senior living and rehabilitative care services through 373 skilled nursing and senior living facilities.
Source: SEC EDGAR, Form 10-K filed Feb 4, 2026 and Form 10-Q filed Oct 27, 2026. Revenue lines are the figures the company tags in its filing; OQRO shows a split only when its lines add up to the reported total revenue. The quote is the opening of the managers' discussion, cut at a sentence; the word count is estimated from its length. Not investment advice.
And 17 more headings in the filing.
Latest annual report filed Feb 4, 2026, compared with the one filed Feb 5, 2025. Read the filing
Indemnities — From time to time, we enter into contracts that contingently require us to indemnify parties against third-party claims. These contracts primarily include (i) certain real estate leases, under which we may be required to indemnify property owners or prior facility operators for post-transfer environmental or other liabilities and other claims arising from our use of the applicable premises, (ii) operations transfer agreements, in which we agree to indemnify past operators of facilities we acquire against certain liabilities arising from the transfer of the operation and/or the…
Source: SEC EDGAR, Form 10-K filed Feb 4, 2026. Headings are the titles the company gives each risk; OQRO compares them with the year before by their words, so a heading that was reworded a lot shows up as both new and no longer listed. Companies list the risks they face, not forecasts.
Off-exchange trading: 41.6% of the shares traded over the latest 4 published weeks changed hands away from the exchanges (30.2% on ATS, 11.4% with other brokers), close to its 26-week average of 40.7%. Weeks of Oct 5 to Oct 30, 2026.
Largest ATS: SIGMA X2 (14.2%), UBS ATS (12.7%), INTELLIGENT CROSS LLC (9.5%), as a share of this stock's ATS volume over the same 4 weeks.
An ATS, often called a dark pool, is a private trading venue run by a broker where orders are not shown publicly before they trade. Other off-exchange trades are mostly retail orders filled by wholesale brokers. A high share is common and says nothing by itself about where the price goes. FINRA OTC Transparency data, published 2 weeks after each week for the largest stocks and 4 weeks for others; total volume from our daily price data.
Last results
Oct 27, 2026
Within the 30 days after it, until Nov 26, 2026
Next results, expected
Feb 2, 2027
after the market closes; the date can move until the company confirms it
Purchases after results
10%
1 of 10 insider purchases since 2016 came within 30 days after a results announcement
From Ensign Group's own results filings (8-K Item 2.02) and its insiders' Forms 4 and 5. Many companies only let insiders trade in a period after results; OQRO does not know Ensign Group's policy and only shows the pattern in the filings. A purchase made long after results, at a company whose insiders usually buy right after them, is marked “Bought outside the usual window”.